Moderna said Tuesday that Phase 2 trial results show that its COVID-19 vaccine is effective in adolescents aged 12 to 17.
Moderna said Tuesday that Phase 2 trial results show that its COVID-19 vaccine is effective in adolescents aged 12 to 17.
Local health leaders say parents now have options